- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 799
SoftBank points OakNorth toward $440m
The digital bank is now valued at $2.8bn, following a $440m round led by a $390m investment by SoftBank Vision Fund and backed by Clermont Group.
Feb 8, 2019Foot Locker kicks $100m into Goat Group
The retailer has invested $100m in footwear marketplace Goat Group, which already counts Matrix Partners, Upfront Ventures, Webb Investment Network and Accel as shareholders.
Feb 8, 2019Corporates help scale Himalaya with $100m
Ximalaya FM and Susquehanna International Group have taken part in a $100m round to launch podcast network Himalaya, which was spun out of Ximalaya.
Feb 8, 2019Waite makes her way to new Millennium
Rita Waite, a Juniper Ventures investment manager who was part of this year's GCV Rising Stars list, will join financial services firm Millennium's payment products team.
Feb 8, 2019Spin Memory banks Abies for series B
NYU and Allied Minds-founded Ram technology developer Spin Memory has unveiled deep tech-focused VC firm Abies Ventures as an investor in a $52m series B first announced late last year.
Feb 8, 2019Ligand Pharmaceuticals administers $3m to Dianomi
Dianomi Therapeutics will work with Ligand on a medication delivery platform based on research from University of Wisconsin-Madison initially targeting pain disorders and osteoarthritis.
Feb 8, 2019Lime climbs to $310m series D
The electric scooter rental platform is now valued at $2.4bn, after securing $310m in a round co-led by GV that included its parent company, Alphabet.
Feb 7, 2019DNAnexus raises $68m in latest funding sequence
GV and WuXi NextCode both returned to back a $68m round for DNANexus, bringing the biomedical informatics platform’s total funding to approximately $173m.
Feb 7, 2019Calm meditates on $88m series B
The meditation app developer has quadrupled its valuation to $1bn in just eight months, in an $88m series B round featuring CAA.
Feb 7, 2019Alector achieves $176m IPO
The AbbVie, Eli Lilly, Amgen, Merck & Co and Alphabet-backed neurodegenerative disease drug developer is floating in the middle of its range.
Feb 7, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


